Navigation Links
Concord Medical Reports Fourth Quarter and Full Year 2012 Financial Results
Date:3/20/2013

to RMB2.82 ($0.45).

Net income excluding share-based compensation expenses (non-GAAP) in 2012 was RMB145.5 million ($23.3 million). Both basic and diluted earnings per ADS excluding share-based compensation expenses (non-GAAP) in 2012 were RMB3.02 ($0.48).

Adjusted EBITDA (non-GAAP) was RMB376.0 million ($60.4 million) in 2012, representing a 18.1% increase from RMB318.4 million in 2011.

Share-based compensation expenses, which were allocated to related operating expense items, were RMB9.1 million ($1.1 million) in 2012, compared to RMB9.2 million in 2011.

Income tax expense in 2012 was RMB61.3 million ($9.8 million), compared to an income tax expense of RMB46.3 million in 2011. The effective tax rate for 2012 was 31% as compared to 28.1% in 2011.

As of December 31, 2012, the Company had total fixed assets valued at RMB1499.6 million ($240.7 million), cash and cash equivalents of RMB75.4 million ($12.1 million), and restricted cash of RMB284.0 million ($45.6 million).

Capital expenditures were RMB391.9 million ($62.9 million) in 2012, compared to RMB339.9 million in 2011.

As of December 31, 2012, the Company had bank credit lines totaling RMB2165.3 million (US$347.6 million), of which RMB765.5 million ($122.9 million) were utilized.

Accounts receivable was RMB213.3 million ($34.2 million) as of December 31, 2012, compared to RMB211.7 million as of September 30, 2012 and RMB244.2 million as of December 31, 2011. Days sales outstanding (DSO) was approximately 86 days in the fourth quarter of 2012 down from 101 days in the third quarter of 2012 and 192 days in the fourth quarter of 2011.  The improved DSO was mainly due to the strengthened efforts during 2012 to accelerate collection from hospital partners, as well as the shorter DSO of Chang'an Hospital.During the fourth quarter of 2012, the Company repurchased 259,202 ADSs, representing 777,606 ordinary shares for a total $1.1 million, including commissio
'/>"/>

SOURCE Concord Medical Services Holdings Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Concord Medical to Report Fourth Quarter and Full Year 2012 Financial Results on March 20, 2013
2. DDS Lab Announces Strategic Alliance with United Concordia
3. Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
4. Concord Medical to Hold Annual General Meeting on December 22, 2012
5. Concord Medical Reports Third Quarter 2012 Financial Results
6. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
7. Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
8. Concord Medical Responds to Unusual Market Activity in its Stock
9. Concord Medical Reports Second Quarter 2012 Financial Results
10. Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
11. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Germany , March 5, 2015 ... today announced that the foundation has made a ... CureVac, a leading clinical-stage biopharmaceutical company specializing in ... the foundation will also provide separate funding for ... CureVac,s proprietary messenger RNA (mRNA) platform. In addition, ...
(Date:3/5/2015)... 5, 2015 CANTEL MEDICAL CORP. (NYSE: ... ended January 31, 2015 on Thursday, March 12 before the ... results at 11:00 AM ET. To participate ... 10 minutes before the beginning of the call. If you ... will be available from Thursday, March 12, 2015 through midnight ...
(Date:3/5/2015)... March 5, 2015   AMC Health , ... recognized for improving the effectiveness and efficiency of ... Robert Anazagasty and Jared Wilstead ... Vice President, Strategic Client Development, and Wilstead will ... support AMC Health,s commitment to accelerating the adoption ...
Breaking Medicine Technology:The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3
... Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a ... Board of Directors has approved the payment of a ... of 2012.  Zimmer,s Board of Directors also has authorized a ... opportunity to initiate a quarterly dividend results from our ...
... Dec. 19, 2011  Valeant Pharmaceuticals International, Inc. (NYSE: ... that effective December 16, 2011, the company completed ... unit of Sanofi (EURONEXT: SAN and NYSE: SNY). ... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: ...
Cached Medicine Technology:Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program 2Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program 3
(Date:3/5/2015)... Supply & Demand Chain Executive Magazine has ... Know” in the supply chain industry, and we are ... team were included on this year’s list! Russ King ... due to their hard work, their commitment to excellence, ... resolving client needs and challenges. , Russ ...
(Date:3/5/2015)... 05, 2015 Dr. Jonathan Glashow a ... ) has been named by Castle Connolly ... area. Dr. Glashow has been selected by Castle Connolly ... the top specialty care doctors in the tri-state metropolitan ... Connolly program, which carefully screens and selects doctors through ...
(Date:3/5/2015)... As a result of the American ... Clearstream, LLC ’s products, services and company philosophies, ... products—led by their mPulse Hand Sanitizer—fits the core ... The AAPA—which represents a profession comprising than 100,000 ... specialties in the U.S.—advocates and educates on behalf ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Today, ... now running on 100% pollution-free electricity through a ... , As an Arcadia Power Clean Energy ... (EPA) Green Power Partnership requirements, joining national brands ... also purchase clean energy. Earth Source Organics joins ...
(Date:3/5/2015)... Park, California (PRWEB) March 05, 2015 ... (JCAP) last week released a special issue ... in the field of PANDAS (Pediatric Autoimmune Neuropsychiatric ... Neuropsychiatric Syndromes), an autoimmune reaction triggered by infections ... lyme, which result in inflammation of the child's ...
Breaking Medicine News(10 mins):Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3
... has been found that elders in hospitals and care homes are ... this, many of them are said to be in hunger// for ... Ivan Lewis. ,Commencing the ‘Dignity for older people’ campaign ... people should be thoroughly understood. When the food is kept far ...
... Pennsylvania School of Medicine have described a new type ... the patient's thoughts, providing two-way signaling for motor control ... at a junction now of developing a new approach ... Smith, MD, Professor of Neurosurgery and Director of the ...
... Scientists have unlocked the secrets of a deadly superbug that attacks ... ,The news is a vital first step in attempts to ... resistant to current antibiotic treatments. ,Already responsible for ... stages of an epidemic that could result in a massive death ...
... study, published in the March 1, 2007 issue of CANCER, ... termination of this highly effective breast cancer drug may negatively ... that over one third of women have ceased tamoxifen treatment. ... quarter of women treated for breast cancer stop tamoxifen within ...
... traits shape up in natural populations,// but one is led ... Two theories have tried to address this challenge – the ... ,The theory of hitchhiking has indicated that genes ... in natural populations when they "hitch a ride" with healthier ...
... whatever the color”, says Dr.Clive Anderson, consultant dermatologist and ... address is part of a move to get Jamaicans ... of the island’s youth resort to bleaching or lightening ... ,Government health officials plan to launch a ...
Cached Medicine News:Health News:New Ideas on Developing Thought-Controlled Artificial Limbs 2Health News:Tamoxifen Discontinuation Rates Surprisingly High 2Health News:The Evolution of Costly Traits 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: